BDBM494719 N-(6-fluoro-2,3-dihydro-1H-inden- 1-yl)-N''-hydroxy-4-((2-(3-(2- methoxyethyl)ureido)ethyl)thio)- 1,2,5-oxadiazole-3-carboximidamide (peak 1)::US10988487, Example 115::US10988487, Example 116

SMILES COCCNC(=O)NCCSc1nonc1\C(NC1CCc2ccc(F)cc12)=N\O

InChI Key InChIKey=JZWZEDACFAQFJW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 494719   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM494719(US10988487, Example 115 | N-(6-fluoro-2,3-dihydro-...)
Affinity DataIC50: 66.3nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM494719(US10988487, Example 115 | N-(6-fluoro-2,3-dihydro-...)
Affinity DataIC50: 3.50E+3nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent